Our recommendations help practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer.
Our updated guideline on menopause emphasises the importance of an individualised approach and shared decision-making when making choices about treatment for symptoms.
Companies who receive scientific advice from our NICE Advice service may experience a faster path to guidance publication, a study has found.
Our associate director of NICE Advice outlines his top tips for healthtech companies, helping them chart a clear path from innovation to NHS adoption.
How we make independent decisions on the cost and clinical effectiveness of medicines and treatments.
Best practice resources for practitioners and commissioners.
Useful sources of information and advice for healthcare professionals, patients, parents and carers.
Summaries of evidence and advice on common health topics (CKS)
Our new guidance recommends hormone replacement therapy (HRT) should be offered as the first treatment option to ease menopause symptoms.
This resource also includes a discussion aid to help GPs give patients the most useful information they can about the HRT drugs and what they do.
On NICE’s 25th anniversary, our partners and collaborators in the health care system discuss what the future holds for NICE.
